2013 WISCONSIN ACT
267
An Act
to renumber
961.34;
to amend
961.14 (4) (t); and
to create
961.34 (2) and 961.38 (1n) of the statutes;
relating to:
providing that cannabidiol is not a tetrahydrocannabinol and dispensing cannabidiol as a treatment for a seizure disorder.
The people of the state of Wisconsin, represented in senate and assembly, do enact as follows:
Section
1
.
961.14 (4) (t) of the statutes is amended to read:
961.14
(4)
(t) Tetrahydrocannabinols, commonly known as "THC", in any form including tetrahydrocannabinols contained in marijuana, obtained from marijuana
,
or chemically synthesized
, except that tetrahydrocannabinols do not include cannabidiol in a form without a psychoactive effect that is dispensed or documented as provided in s. 961.38 (1n)
;
Section
1h
.
961.34 of the statutes is renumbered 961.34 (1).
Section
1j
.
961.34 (2) of the statutes is created to read:
961.34
(2)
(a) Upon the request of any physician, the controlled substances board shall aid the physician in applying for and processing an investigational drug permit under
21 USC 355
(i) for cannabidiol as treatment for a seizure disorder. If the federal food and drug administration issues an investigational drug permit, the controlled substances board shall approve which pharmacies and physicians may dispense cannabidiol to patients.
(b) If cannabidiol is removed from the list of controlled substances, or if cannabidiol is determined not to be a controlled substance, under schedule I of
21 USC 812
(c), the controlled substances board shall approve which pharmacies and physicians may dispense cannabidiol to patients as treatment for a seizure disorder.
Section
2
.
961.38 (1n) of the statutes is created to read:
961.38
(1n)
A pharmacy or physician approved under s. 961.34 (2) (a) or (b) may dispense cannabidiol in a form without a psychoactive effect as a treatment for a seizure disorder or any physician may provide an individual with a hard copy of a letter or other official documentation stating that the individual possesses cannabidiol to treat a seizure disorder if the cannabidiol is in a form without a psychoactive effect.
